CASE STUDY | ADVERTISING
When Brand Performance Stalled, We Reframed the Narrative.
THE CHALLENGE
Stalled Brand Performance in a Competitive Oncology Market
A leading pharmaceutical company faced increasing pressure within a highly competitive oncology market. Patient requests for the therapy had leveled off at approximately 20–25% over recent quarters, signaling an opportunity to strengthen the current campaign.
At the same time, patient recall of existing advertising fluctuated with changes in media investment, highlighting the need for a more consistent and memorable approach.
To improve performance, the brand needed a clearer, more emotionally resonant positioning strategy that could strengthen engagement across patient and HCP audiences.
THE BREAKTHROUGH
Reframing Treatment Around How Patients Want to Live
BGBx identified that existing category narratives were limiting how patients related to treatment. Most brands focused on either fighting disease or accepting its limitations, approaches that did not reflect how patients saw themselves or how they wanted to live. The breakthrough repositioned the therapy around a more relevant, patient-centered perspective, focusing on the ability to continue living life as intended.
Using our proprietary Breakthrough Process, powered by 3D Science, we validated the strategy at every stage of development. Hypotheses were tested against market realities, strategic concepts were validated with target audiences, and creative execution was proven before scaling investment. This ensured the positioning would resonate across both patient and HCP audiences.
The approach integrated:
- Patient-centered positioning that moved beyond disease-focused messaging
- AI-supported concept development to rapidly generate and refine visual territories
- Creative testing to pressure-test composition, tone, and effectiveness before production
- Omnichannel activation across broadcast, DTC, social, and HCP digital channels
- Patient support tools and integrated materials spanning patient and provider audiences
This created a unified brand experience and a more emotionally resonant campaign across touchpoints.
THE RESULTS
Improved Brand Performance and Engagement
- Achieved a leading position as the most requested ARPI within its category
- Improved brand linkage through record-breaking TV performance
- Expanded reach across patient and HCP audiences
- Increased intent to visit oncology compared with the previous campaign
The result was stronger brand performance and increased engagement across both patient and HCP audiences.
#1
Most Requested ARPI
Achieved leading position
within its category
96% Brand Linkage
Record-breaking
TV performance
18%
Intent to Visit Oncology
Increase from
previous campaign
Our Perspectives on Advertising

2026 Oncology Market Access Trends

Implications of the IRA’s Maximum Fair Price (MFP) Negotiations

340B Drug Discount Program
Leading the Conversation iLorim Ipsum
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.


